Parallel Advisors, LLC Atri Cure, Inc. Transaction History
Parallel Advisors, LLC
- $4.31 Billion
- Q1 2025
A detailed history of Parallel Advisors, LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 7,229 shares of ATRC stock, worth $216,219. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,229
Previous 6,396
13.02%
Holding current value
$216,219
Previous $195,000
17.95%
% of portfolio
0.01%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding ATRC
# of Institutions
230Shares Held
46.3MCall Options Held
25.8KPut Options Held
4.5K-
Vanguard Group Inc Valley Forge, PA4.65MShares$139 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$138 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.84MShares$115 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.92MShares$87.4 Million1.54% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.53MShares$75.6 Million0.51% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.39B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...